Your browser doesn't support javascript.
loading
High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis.
Wang, Chun-yu; Deng, Jia-ying; Cai, Xu-wei; Fu, Xiao-long; Li, Yuan; Zhou, Xiao-yan; Wu, Xiang-hua; Hu, Xi-chun; Fan, Min; Xiang, Jia-qing; Zhang, Ya-wei; Chen, Hai-quan; Perez, Rolando; Jiang, Guo-liang; Zhao, Kuai-le.
Afiliación
  • Wang CY; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Deng JY; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Cai XW; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Fu XL; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Li Y; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhou XY; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wu XH; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Hu XC; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Fan M; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xiang JQ; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhang YW; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Chen HQ; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Perez R; Center of Molecular Immunology, Havana, Cuba.
  • Jiang GL; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhao KL; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Oncotarget ; 6(21): 18674-82, 2015 Jul 30.
Article en En | MEDLINE | ID: mdl-26124180
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Proteínas Proto-Oncogénicas c-akt / Anticuerpos Monoclonales Humanizados / Receptores ErbB Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Proteínas Proto-Oncogénicas c-akt / Anticuerpos Monoclonales Humanizados / Receptores ErbB Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article País de afiliación: China